Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples

We previously demonstrated that amplified in breast cancer 1 (AIB1) and eukaryotic initiation factor 2 (EIF5A2) overexpression was an independent predictor of poor clinical outcomes for patients with bladder cancer (BCa). In this study, we evaluated the usefulness of AIB1 and EIF5A2 alone and in com...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Bang-Fen, Wei, Jin-Huan, Chen, Zhen-Hua, Dong, Pei, Lai, Ying-Rong, Fang, Yong, Jiang, Hui-Ming, Lu, Jun, Zhou, Fang-Jian, Xie, Dan, Luo, Jun-Hang, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173089/
https://www.ncbi.nlm.nih.gov/pubmed/27203388
http://dx.doi.org/10.18632/oncotarget.9406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173089/
https://www.ncbi.nlm.nih.gov/pubmed/27203388
http://dx.doi.org/10.18632/oncotarget.9406

Ejemplares similares